DUBLIN, Mar. 24, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/ccv4lk/research_and) has announced the addition of the "Research and Investment Forecast Evaluation of China's Enteral Nutrition Preparation Market from 2015 to 2020" report to their offering.
Enteral nutrition preparations are the main varieties in enteral nutrition support treatment. The oral enteral nutrition emulsion and suspension include TPF, TP, TPF-T and TP-HE etc different formulas. The main manufacturers are Sino-Swed Pharmaceutical Corp, Ltd. (SSPC) and Nutricia (Wuxi), the former mainly includes such brands as: Fresubin Energy Fibre, Fresubin, Supportan and Fresubin MCT 750; while the later mainly includes Nutrison fibre, Nutrison, Peptisorb Liquid and Diason etc brands.
In China, the clinical nutrition market started in 1960s-70s. After entered into China market in 1982, China-Germany joint venture Sino-Swed Pharmaceutical is the first enterprise launching fat emulsion, amino acid and other products into market. With tens of years of development, the market is segmented increasingly, each variety increases rapidly.
In recent years, with the popularization of clinical nutrition conception in China, more and more domestic enterprises set foot in this field. According to statistics, in 2010, the market scale of enteral nutrition preparation was CNY 2.21 billion in China, by the end of 2014, it was CNY 4.11 billion and increases continually.
In overall, at present, the clinical nutrition is still in development stage in China, the home-made clinical nutrition preparations still far lag behind overseas level in respects of both quality and variety, the high-grade product market is monopolized by the imported or joint-venture products. With the constant upgrades of clinical academic concepts, from the original intravenous hyperalimentation, to equal nitrogen, equal thermal treatment, to low nitrogen, low calorie parenteral nutrition solution, to enteral nutrition and to joint nutrition treatment theory, higher requirements on convenience and safety of clinical nutrition products are put forward, especially, the emergence of infusion method of All-in-one nutrient solution makes the concept: parenteral nutrition should give the most reasonable infusion method, become common sense clinically.
Key Topics Covered:
1. Overview of China's Enteral Nutrition Preparation Product
2. Enteral Nutrition Preparation in Overseas Markets
3. Environment Analysis of Enteral Nutrition Preparation
4. Market Characteristics of Enteral Nutrition Preparation
5. Development of Enteral Nutrition Preparation in China
6. Analysis on Enteral Nutrition Preparation in China
7. of Import & Export Analysis
8 Technical Development of Enteral Nutrition Preparation in China
9. Key Manufacturers and Competition Pattern in China
10 Investment Suggestions on Enteral Nutrition Preparation in China
12 Investment Suggestions and Opinions from Industry Experts
- Netherlands Nutricia
- Sino-Swed Pharmaceutical Corp, Ltd. (SSPC)
- Abbott Laboratories
- NOVARTIS Pharmaceutical Co.,Ltd
- Xi'an Libang Clinical Nutrition Limited Company
For more information visit http://www.researchandmarkets.com/research/ccv4lk/research_and
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets